u/nplusyears

What do you do with the “I’m not as sharp as I used to be” patient?

Saw a 47-year-old man today working in education who said he feels like he’s “losing his mental edge.”

Not overt memory loss. Still functioning independently. Mainly describing reduced focus, slower thinking, less mental sharpness compared to a few years ago.

Basic workup was unremarkable including B12, TSH, ferritin, etc.

He asked about supplements/nootropics. I mostly emphasized sleep, physical activity, diet, stress, abdominal adiposity, etc. But honestly I left the visit thinking how difficult this category of complaint is in primary care.

These patients are usually not demented or clearly MCI, but many genuinely feel cognitively different.

And I’m never fully sure what to make of it..

Sometimes it’s sleep/stress/metabolic health. Sometimes depression/anxiety presenting this way. Sometimes people noticing normal aging for the first time. And sometimes you’re left asking yourself whether this is the very beginning of something you still can’t detect clinically.

I also struggle with how objective to get when labs and day-to-day functioning are still normal.

Curious how others approach this group clinically.

Do you quantify objectively in some way?

Use screening tools?

Treat mainly through lifestyle/metabolic risk?

Refer?

Or mostly reassure and follow longitudinally?

reddit.com
u/nplusyears — 4 days ago

After a day of clinic task-switching and inbox work, does anyone else struggle to think deeply afterward?

Does anyone else feel like clinic work changes your brain’s “mode” of thinking?

After a day of rapid task-switching- messages, refills, interruptions, acute complaints, documentation.. I find it surprisingly hard to return to slower, focused thinking afterward (reading deeply, writing, studying, working on projects, etc).

It feels almost like attention fragmentation persists after work ends.

Curious whether others experience this, and whether you found ways to recover that deeper cognitive mode.

reddit.com
u/nplusyears — 6 days ago

Methylene blue for longevity- trying to assess it as a physician

I’ve been looking more seriously into methylene blue recently after seeing it come up repeatedly in longevity / biohacking discussions.

Methylene blue is unusual because it sits in a strange space between medication, research compound, and supplement.

It has real medical indications, mainly methemoglobinemia- a condition where hemoglobin loses its ability to carry oxygen effectively, sometimes after medication or chemical exposure. In that setting, methylene blue is usually given as monitored short-term treatment, often IV.

That’s very different from the way it’s currently being used off-label in longevity circles:

usually oral, often daily or near-daily, sometimes chronically, and at doses ranging from microdosing all the way up to double-digit mg regimens.

I can see why people get interested in it.

The proposed mechanisms are relevant to areas people care about in aging and cognition:

mitochondrial electron transport, redox cycling, oxidative stress signaling, ATP production, neuroprotection.

There are also some preclinical findings that look interesting at first glance:

- fibroblast / reconstructed skin models

- rodent neurodegeneration models

- some cognition-related animal work

Most of the data I found, though, was:

- disease-model based rather than aging itself

- relatively short follow-up

- focused on surrogate markers rather than functional outcomes

And to be fair, that’s true for a large part of longevity medicine right now, not just methylene blue..

We rarely get direct lifespan data in humans. So the practical question becomes which surrogate outcomes are strong enough to take seriously:

frailty, cognition, function, ASCVD risk, disability, cancer risk, etc.

At the moment, I don’t think the human evidence for methylene blue is strong enough there yet.

The toxicology side also became harder to ignore the more I read:

- MAO inhibition / serotonergic interactions

- G6PD-related hemolysis risk

- dose-dependent oxidative effects

- formulation purity issues outside pharmaceutical products

And unlike standard medications, we have very limited long-term safety data for healthy people taking it chronically for prevention or longevity purposes.

Personally, I ended up somewhere in the middle on this compound.

Interesting enough that I understand why people experiment with it.

But not convincing enough that I’d currently view it as an established longevity intervention.

Curious how others here think about it, especially anyone who dug into the human data or tried to think through the risk/benefit side beyond the mechanism diagrams.

reddit.com
u/nplusyears — 8 days ago

Has anyone here ever tried blinding themselves with a supplement that felt obviously effective?

Something for focus, energy, sleep, anxiety etc.

Like using identical capsules, mixing placebo/active, having someone randomize them without telling you which is which..

Genuinely curious what happened.

Did the effect still feel obvious once expectation was removed?

reddit.com
u/nplusyears — 14 days ago

I keep saving papers from Twitter “for later.”

That later rarely comes..

Not from lack of interest, just the volume and pace are different now.

Between clinic and life (family doc, high-volume practice, young kids), it’s hard to find time for deep reading like in med school.

Curious how others are handling this-any system that actually works?

reddit.com
u/nplusyears — 22 days ago